Lung cancer
Conditions
Interventions
Group A:Iodide implantation combined chemotherapy treatment
Group B:Iodide implantation combined Chinese herbal medicine treatment
Group C:Iodide implantation
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients with accurate pathology and radiographic evidence of advanced non-small-cell lung cancer (III and IV), and cannot be surgically removed; 2.None of the patients received radiotherapy, chemotherapy and targeted therapy before I125 seed implantation therapy; 3.Patients were willing to accept surgical treatment and follow-up investigation.
Exclusion criteria
Exclusion criteria: 1.Lung tumor lesions had a wide range of distant metastases; 2.Life expectancy = 7 cm; 4.Patients had received brachytherapy, chemotherapy and Chinese herbal medicine treatment at the same time; 5.All patients had low cardiopulmonary function, cachexia with multifunctional failure and other surgical contraindications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications; | — |
Countries
China
Contacts
Public ContactWu Qingchen
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed